May 23, 2022 / 08:15PM GMT
John Newton Sourbeer - UBS Investment Bank, Research Division - Equity Research Associate
Hi. I'm John Sourbeer, UBS' life science tools and pharma services analyst. Welcome to the last panel of the day, of day 1 of the UBS Healthcare Conference. We have -- we're hosting Codexis for this fireside chat, and we have John Nicols, President and CEO.
John J. Nicols - Codexis, Inc. - President, CEO & Director
Pleasure to be here. Thanks.
Questions and Answers:
John Newton Sourbeer - UBS Investment Bank, Research Division - Equity Research AssociateJust to get things started, can you provide an overview of Codexis' business model and the different spaces you're involved in as a company? How did you get here? And where do you want to go in the future?
John J. Nicols - Codexis, Inc. - President, CEO & Director
Awesome. Yes, pleasure. So Codexis, we're a 20-year-old company. We've been focused our entire history on enzymes as a class of products to discover and